Genmab A S (GMAB)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 706 |
| % of all portfolios: | 0.006% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q3 2023 | |||||
| ≡ | Torray Funds | Reduce 3.93% | 4,276 | 0.03 | |
| Q2 2023 | |||||
| ≡ | Torray Funds | Reduce 1.82% | 2,015 | 0.01 | |
| Q1 2023 | |||||
| ≡ | Torray Funds | Reduce 13.81% | 17,757 | 0.12 | |
| Q4 2022 | |||||
| ≡ | Torray Funds | Reduce 2.18% | 2,866 | 0.02 | |
| Q3 2022 | |||||
| ≡ | Torray Funds | Reduce 0.21% | 278 | 0.00 | |
| Q2 2022 | |||||
| ≡ | Torray Funds | Reduce 1.10% | 1,464 | 0.01 | |
| Q1 2022 | |||||
| ≡ | Torray Funds | Reduce 4.46% | 6,218 | 0.04 | |
| Q4 2021 | |||||
| ≡ | Torray Funds | Reduce 4.33% | 6,308 | 0.04 | |
| Q3 2021 | |||||
| ≡ | Torray Funds | Reduce 0.73% | 1,076 | 0.01 | |
| Q1 2021 | |||||
| ≡ | Viking Global Investors | Sell 100.00% | 377,562 | 0.04 | |
| Q4 2020 | |||||
| ≡ | Viking Global Investors | Reduce 0.22% | 842 | 0.00 | |
| ≡ | Torray Funds | Reduce 4.14% | 6,266 | 0.04 | |
| Q3 2020 | |||||
| ≡ | Torray Funds | Reduce 3.30% | 5,176 | 0.03 | |
| ≡ | Viking Global Investors | Reduce 34.20% | 196,682 | 0.03 | |
| Q2 2020 | |||||
| ≡ | Torray Funds | Reduce 12.70% | 22,786 | 0.15 | |
| ≡ | Viking Global Investors | Reduce 31.62% | 265,899 | 0.04 | |
| Q4 2019 | |||||
| ≡ | Viking Global Investors | Reduce 1.29% | 7,657 | 0.00 | |
| ≡ | Torray Funds | Reduce 77.13% | 539,421 | 2.06 | |
| Q2 2019 | |||||
| ≡ | Torray Funds | Reduce 4.52% | 32,335 | 0.06 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.